RBFOX3 and neoplasm: We tested this hypothesis by establishing a B16‐EGFP tumor‐bearing model using normal B16‐EGFP cells, Rbfox3 knockout B16‐EGFP cells, or Nbr1 knockout B16‐EGFP cells.